Stay updated on Chemoradiotherapy +/- Pembrolizumab in Cervical Cancer Clinical Trial
Sign up to get notified when there's something new on the Chemoradiotherapy +/- Pembrolizumab in Cervical Cancer Clinical Trial page.

Latest updates to the Chemoradiotherapy +/- Pembrolizumab in Cervical Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedNew navigation/help items were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment header was added while the Intervention / Treatment header formatting was removed, with the revision label updated from v3.5.5 to v3.6.0. Additionally, the page now displays 'No longer looking for participants,' indicating that enrollment has ended.SummaryDifference0.1%

- Check21 days agoChange DetectedThe site’s revision metadata was updated from v3.5.4 to v3.5.5, signaling a new build of the page template. This update does not change the study data or content on the page.SummaryDifference0.0%

- Check28 days agoChange DetectedThe study location listing for Kharkiv has been updated from Kharkivs’ka Oblast’ and the old city/address line to Kharkiv Oblast and Kharkiv, Kharkiv Oblast, Ukraine, 61024.SummaryDifference0.0%

- Check36 days agoChange DetectedA new PubMed citation about patient-reported outcomes from the phase 3 ENGOT-cx11/GOG-3047/KEYNOTE-A18 trial has been added to the Publications section. A note clarifies that these publications are automatically filled from PubMed and may not all be about the study.SummaryDifference0.1%

- Check43 days agoChange DetectedThe page revision has been updated from v3.5.3 to v3.5.4, indicating a minor maintenance update to the study record page.SummaryDifference0.0%

- Check57 days agoChange DetectedAdded Taoyuan, Taiwan, 333 to the study locations and removed Taoyuan District, Taiwan, 333 from the list, updating the Taiwan sites to reflect a city-level entry.SummaryDifference0.0%

Stay in the know with updates to Chemoradiotherapy +/- Pembrolizumab in Cervical Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Chemoradiotherapy +/- Pembrolizumab in Cervical Cancer Clinical Trial page.